{"id":"tj101","safety":{"commonSideEffects":[{"rate":null,"effect":"Unknown"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"TJ101 works by binding to [insert target here, if known] and [insert mechanism here, if known].","oneSentence":"TJ101 is a small molecule that targets the [insert target here, if known].","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:39:06.658Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Phase 3 for [insert indication here, if known]"}]},"trialDetails":[{"nctId":"NCT07300436","phase":"PHASE1","title":"A Study of TJ101 Injection Before and After CMC Change Following Subcutaneous Injection in Healthy Adult Male Subjects in China","status":"RECRUITING","sponsor":"TJ Biopharma Co., Ltd.","startDate":"2026-01-04","conditions":"Healthy Adult Males in China","enrollment":96},{"nctId":"NCT07181473","phase":"PHASE1","title":"A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors","status":"RECRUITING","sponsor":"Phrontline Biopharma","startDate":"2025-08-25","conditions":"Lung Cancer (NSCLC), Prostate Cancer, Esophageal Cancer","enrollment":200},{"nctId":"NCT04633057","phase":"PHASE3","title":"A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"TJ Biopharma Co., Ltd.","startDate":"2021-01-25","conditions":"Pediatric Growth Hormone Deficiency","enrollment":168}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"TJ101","genericName":"TJ101","companyName":"TJ Biopharma Co., Ltd.","companyId":"tj-biopharma-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"TJ101 is a small molecule that targets the [insert target here, if known]. Used for Phase 3 for [insert indication here, if known].","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}